Symbols

ICCC

Immucell·NASDAQ

--(--)

8.36 / 10

Outperform

Analyst sentiment is neutral‑hold after Weiss upgrade; consensus remains hold. Fund‑flow sentiment is excellent (8.36/10) with strong inflows from block, large and extra‑large investors, though small and medium investors are net negative. Capital is flowing in, supporting a positive short‑term bias.

Fund Flow Rating

What is the market sentiment for ICCC?

ICCC holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.36/10 (Outperform).